Luteolin and chicoric acid, two major constituents of dandelion leaf, inhibit nitric oxide and lipid peroxide formation in lipopolysaccharide- stimulated raw 264.7 cells

Journal of Food Science and Nutrition

Volumn 15, Issue 2, 2010, Pages 92-97

  Park, Chung Mu ^a   Park, Ji Young ^b   Song, Young Sun ^a  

^a Inje University   (South Korea)

^b Sambang High School   (South Korea)

Author keywords

Chicoric acid; Lipid peroxide; Luteolin; Nitric oxide; Taraxacum officinale

Indexed keywords

TARAXACUM OFFICINALE;

EID: 78651393106     PISSN: 1226332X     EISSN: None     Source Type: Journal    
DOI: 10.3746/jfn.2010.15.2.092     Document Type: Article

References (28)

1. Tracey KJ, Cerami A. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45: 491-503.
2. Akira S, Taga T, Kishimoto T. 1993. Interleukin-6 in biology and medicine. Adv Immunol 54: 1-78. (Pubitemid 23289250)
3. Nathan C, Xie QW. 1994. Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728. (Pubitemid 24191108)
4. Rathmell JC, Thompson CB. 1999. The central effectors of cell death in the immune system. Annu Rev Immunol 17: 781-828. (Pubitemid 29241140)
5. Dargel R. 1992. Lipid peroxidation-a common pathogenetic mechanism?. Exp Toxicol Pathol 44: 169-181.
6. Bisset NG, Wichtl M. 1994. Herbal drugs and phytopharmaceuticals: a handbook for practice on a scientific basis. 2nd ed. CRC Press, New York, USA.
7. Newall CA, Anderson LA, Phillipson JD. 1996. Herbal medicines: a guide for health-care professionals. Pharmaceutical Press, London, UK.
8. Racz-Kotilla E, Racz G, Solomon A. 1974. The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med 26: 212-217.
9. Williams CA, Goldstone F, Greenham J. 1996. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry 42: 121-127.
10. Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. 2006. Luteolin and chrysin differentially inhibit cyclooxygenase- 2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr 136: 1517-1521. (Pubitemid 43765355)
11. Stevenson LM, Matthias A, Banbury L, Penman KG, Bone KM, Leach DL, Lehmann RP. 2005. Modulation of macrophage immune responses by Echinacea. Molecule 10: 1279-1285. (Pubitemid 43349749)
12. D'Agostino P, Ferlazzo V, Milano S, La Rosa M, Di Bella G, Caruso R, Barbera C, Grimaudo S, Tolomeo M, Feo S, Cillari E. 2001. Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line. Int Immunopharmacol 1: 1765-1776. (Pubitemid 32772647)
13. Fautz RB, Husein B, Hechenberger C. 1991. Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutat Res 253: 173-179.
14. Fraga CG, Leibovitz BE, Tappel AL. 1988. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med 4: 155-161. (Pubitemid 18052530)
15. Kolb H, Kolb-Bachofen V. 1992. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 13: 157-160.
16. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. 1995. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496.
17. Gobert AP, Mersey BD, Cheng Y, Blumberg DR, Newton JC, Wilson KT. 2002. Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol 168: 6002-6006. (Pubitemid 34620013)
18. van Acker SA, van den Berg DJ, Tromp MN, Griffioen DH, van Bennekom WP, van der Vijgh WJ, Bast A. 1996. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 20: 331-342. (Pubitemid 26077855)
19. Noguchi N, Niki E. 2000. Phenolic antioxidants: a rationale for design and evaluation of novel antioxidant drug for atherosclerosis. Free Radic Biol Med 28: 1538-1546. (Pubitemid 30604237)
20. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. 1997. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 65: 1489-1494. (Pubitemid 27187762)
21. Knekt P, Jarvinen R, Reunanen A, Maatela J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312: 478-481. (Pubitemid 26061237)
22. Doll R. 1990. An overview of the epidemiological evidence linking diet and cancer. Proc Nutr Soc 49: 119-131.
23. Kim HM, Shin HY, Lim KH, Ryu ST, Shin TY, Chae HJ, Kim HR, Lyu YS, An NH, Lim KS. 2000. Taraxacum officinale inhibits tumor necrosis factor-alpha production from rat astrocytes. Immunopharmacol Immunotoxicol 22: 519-530. (Pubitemid 30614770)
24. Hagymasi K, Blazovics A, Feher J, Lugasi A, Kristo ST, Kery A. 2000. The in vitro effect of dandelions antioxidants on microsomal lipid peroxidation. Phytother Res 14: 43-44. (Pubitemid 30087950)
25. Koo HN, Hong SH, Song BK, Kim CH, Yoo YH, Kim HM. 2004. Taraxacum officinale induces cytotoxicity through TNF-alpha and IL-1alpha secretion in Hep G2 cells. Life Sci 74: 1149-1157.
26. Hu C, Kitts DD. 2004. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem 265: 107-113. (Pubitemid 41461870)
27. Schultz K, Carle R, Schieber A. 2006. Taraxacum-a review on its phytochemical and pharmacological profile. J Ethnopharmacol 107: 313-323. (Pubitemid 44344437)
28. Sevanian A, Ursini F. 2000. Lipid peroxidation in membranes and low-density lipoproteins: similarities and differences. Free Radic Biol Med 29: 306-311.